We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pig Tissue Transplant May Reduce Stroke Damage

By HospiMedica staff writers
Posted on 14 Sep 2004
In a recent study, researchers put porcine choroids plexus tissue into biocompatible microcapsules and then transplanted these into a rat stroke model, which showed a 65% reduction in the size of the stroke as well as recovery in motor and neurologic function. More...
The findings were reported in the September 2004 issue of Stroke.

The cells of the porcine choroid plexus are similar in size and function to human cells and thus can be used in humans. The tissue secretes brain-nourishing neurotrophic factors. Pig brain tissue has previously been used in humans to treat Parkinson's disease.

The researchers found that while the tissue works well without any capsule, this leads to increased inflammation. The capsules were created by LCTBioPharma, Inc. (Providence, RI, USA). They are designed to allow molecules such as protective neurotrophic factors to escape and keep out inflammatory factors that could trigger an immune response and rejection.

"What we have seen is the reduction of the size of the stroke in the brain, and the animals that received the transplant showed functional recovery in motor as well as neurological function,” said first author Dr. Cesario V. Bolongan, neuroscientist at the Medical College of Georgia (Augusta, USA). "There are different therapies we can combine with this encapsulated therapy, including other substances such as stem cells to help replace brain cells that are lost.”




Related Links:
Medical College of Georgia

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.